MINNEAPOLIS, Jan. 24 /PRNewswire-FirstCall/ -- Vascular Solutions, Inc. and B. Braun Medical, Inc. today announced that they have extended their agreement for a second contract year for the inclusion of Vascular Solutions’ D-Stat Dry(TM) hemostatic bandage with B. Braun Medical’s vena cava filters sold in the U.S.
The agreement provides for the purchase by B. Braun Medical of individual units of the D-Stat Dry hemostatic bandage from Vascular Solutions for inclusion with B. Braun Medical’s vena cava filter systems. Following the physician’s implantation of Braun’s vena cava filter, the D-Stat Dry hemostatic bandage can be applied to the puncture site for assistance in rapidly achieving hemostasis. Under the terms of the extension, B. Braun Medical’s purchases of the D-Stat Dry will continue through March 2006.
“We are very pleased with the competitive advantage we’ve received over the last year by including the D-Stat Dry bandage with our vena cava filter kits,” commented Amber Kingston, Vascular Interventional Product Director of B. Braun Medical. “Our customers appreciate the convenience of including the D-Stat Dry with our Vena Tech LP vena cava filter system, and the clinical results we have seen in the first year have been impressive.”
Howard Root, CEO of Vascular Solutions, Inc. commented: “We appreciate B. Braun’s continuation of this agreement to the benefit of both parties. In addition to the increased revenue to Vascular Solutions, over the last year we have benefited from the added visibility within the Interventional Radiology market generated by B. Braun Medical’s product and sales force. We are pleased to continue these benefits into a second year.”
ABOUT B. BRAUN
Since its founding in 1839, B. Braun has built an unparalleled store of knowledge and expertise in delivering innovative healthcare products, medical devices and programs that enhance both patient and health-professional safety. Its 29,000 employees worldwide are proud of their commitment to translating customer needs into products with unmatched quality, superior technology, cost-effectiveness and environmental responsibility.
Through its “Sharing Expertise(TM)” initiative, B. Braun promotes best practices for continuous improvement of healthcare products and services. For more information about B. Braun or its safety healthcare products, call 800- 854-6851, or visit B. Braun at http://www.bbraunusa.com/ .
ABOUT VASCULAR SOLUTIONS
Vascular Solutions, Inc. is a medical device company that focuses on developing unique solutions for unmet clinical opportunities within Interventional Radiology and Interventional Cardiology. New products introduced since the second half of 2003 include the Vari-Lase(R) endovenous laser product line for the treatment of varicose veins, the D-Stat Dry(TM) hemostatic bandage for the rapid control of topical bleeding and the Pronto(TM) extraction catheter for the mechanical extraction of soft thrombus. The Company’s other products include the Duett(TM) sealing device to rapidly seal the puncture site following catheterization procedures, the D-Stat(R) Flowable hemostat for the local management of active bleeding, and the Acolysis(R) intravascular therapeutic ultrasound product which is sold in international markets for the treatment of peripheral occlusive arterial disease.
The information in this press release contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements. Important factors that may cause such differences include those discussed in our Annual Report on Form 10-K for the year ended December 31, 2003 and other recent filings with the Securities and Exchange Commission. The risks and uncertainties include, without limitation, risks associated with our limited operating history, need for adoption of our new products, lack of profitability, exposure to possible intellectual property claims, dependence on key vendors, exposure to possible product liability claims, the development of new products by others, doing business in international markets, limited manufacturing experience, the availability of third party reimbursement, and actions by the FDA.
For further information, connect to http://www.vascularsolutions.com/ .
Vascular Solutions, Inc.
CONTACT: Howard Root, CEO, or James Hennen, CFO, both of VascularSolutions, Inc., +1-763-656-4300, or Amber Kingston, Product Director,B. Braun Interventional Product Group, +1-610-997-4459